Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Capital Expenditures (2016 - 2021)

Kraig Biocraft Laboratories (KBLB) has disclosed Capital Expenditures for 8 consecutive years, with $17233.0 as the latest value for Q4 2021.

  • Quarterly Capital Expenditures changed N/A to $17233.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $97154.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $5395.0 for FY2025, 27.24% up from the prior year.
  • Capital Expenditures hit $17233.0 in Q4 2021 for Kraig Biocraft Laboratories, down from $74801.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $74801.0 in Q3 2021 to a low of $1304.0 in Q2 2018.
  • Historically, Capital Expenditures has averaged $13976.9 across 3 years, with a median of $5687.5 in 2018.
  • Biggest YoY gain for Capital Expenditures was 350.97% in 2018; the steepest drop was 92.67% in 2018.
  • Year by year, Capital Expenditures stood at $6997.0 in 2017, then crashed by 44.42% to $3889.0 in 2018, then soared by 343.12% to $17233.0 in 2021.
  • Business Quant data shows Capital Expenditures for KBLB at $17233.0 in Q4 2021, $74801.0 in Q3 2021, and $5120.0 in Q2 2021.